CRMD
CorMedix Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.43
−0.47%Aug 13, 2026, 15:07 UTC
CorMedix signed a multiyear commercial supply agreement for DefenCath with an additional large dialysis organization, completing supply agreements with each of the five largest U.S. dialysis providers.
Source:Jul 1, 2026, 00:00 UTC
CorMedix Inc. dismissed CBIZ CPAs P.C. as its independent registered public accounting firm and engaged Ernst & Young LLP as its new auditor, effective June 25, 2026.
Jun 8, 2026, 12:30 UTC
The U.S. Court of Appeals for the Federal Circuit affirmed a judgment that patents covering CorMedix Therapeutics' MINOCIN are valid and infringed by Nexus Pharmaceuticals' product.
Source: